Generic Drug Deals Are Getting Rarer

by | May 24, 2017 8:33 pm | Pharmaceuticals | 0 comments

The patent cliff is boosting the volume and market share of generic pharmaceutical products. Generics account for 88% of all prescriptions filled annually in the United States, according to the latest IMS Report. For good reason, since generic drugs typically cost between 50% to 70% less than their branded equivalents. Governments and managed care companies have historically been proponents of generic drugs, which can lower the cost of healthcare across the entire continuum. 2015 was the year of the M&A boom in the generic drug segment, with 25 deals totaling $64.8 billion. The targets include the companies focused on generic pharmaceuticals as well as the... Read More »

Pfizer Sells Hospira’s Infusion Therapy Business

by | Oct 4, 2016 3:22 pm | Pharmaceuticals | 0 comments

Way back in February 2015, Pfizer Inc. (NYSE: PFE) agreed to pay $17 billion to acquire Hospira, Inc., a global provider of injectable drugs and infusion technologies. In early October 2016, Pfizer agreed to sell Hospira’s infusion therapy business to ICU Medical Inc. (NASDAQ: ICUI) for $1 billion in cash and stock. The company develops, manufactures and sells medical devices used in infusion therapy, oncology and critical care applications. Pfizer will receive approximately $400 million in newly issued shares of ICU Medical common stock and $600 million in cash from ICU, for a total purchase price of approximately $1 billion. Upon completion, Pfizer will own approximately 16.6% of... Read More »

Premier, Inc. Makes Two eHealth Deals

by | Aug 17, 2015 4:27 pm | eHealth | 0 comments

August is a busy month for Premier, Inc. (NASDAQ: PINC), which bills itself as a healthcare improvement company, with an alliance of 3,400 hospitals and 110,000 other providers. In the first two weeks of August 2015, the company has announced two acquisitions totaling $465 million. The first deal, for CECity, Inc. was announced on August 4 ($400 million); the second, for Healthcare Insights, LLC, was announced on August 12 ($65 million). The former company specializes in performance improvement, while the latter provides financial management systems to hospitals and healthcare systems. In August 2014, Premier acquired TheraDoc, a clinical informatics company, from Hospira (NYSE: HSP) for... Read More »

Year’s Biggest Billion-Dollar Deals Top $64 Billion

by | Mar 16, 2015 8:16 pm | Biotechnology, Pharmaceuticals | 0 comments

Already in 2015, we’ve recorded 11 billion-dollar-plus deals, for a total of $64.4 billion. Thanks to the $21 billion AbbVie (NYSE: ABBV) bid for Pharmacyclics (NASDAQ: PCYC), the biotechnology sector accounted for $27.5 billion of those big deals. Pharmaceuticals, with four billion-plus transactions, still ranks first, with combined spending of $30.45 billion.  Read More »